NOVAVAX INC Intellectual Property Contracts & Agreements
8 Contracts & Agreements
- License Agreements (8 contracts)
- Amended and Restated Supply and License Agreement, dated July 1, 2021, between Novavax, Inc. and Serum Institute of India Private Limited (Filed With SEC on November 5, 2021)
- Second Amended and Restated Novavax Product License Agreement between Novavax, Inc. and CPL Biologicals Private Limited, dated as of July 17, 2018 (Filed With SEC on November 7, 2018)
- [**] = Portions of this exhibit have beenomitted pursuant to a confidential treatment request. An unredacted version of this exhibit hasbeen filed separately with the Commission.... (Filed With SEC on September 8, 2015)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on August 10, 2009)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on May 11, 2009)
- LICENSE AND DEVELOPMENT AGREEMENT (Filed With SEC on August 14, 2006)
- SECOND AMENDMENT TO THE EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (Filed With SEC on August 13, 2001)
- FIRST AMENDMENT TO THE EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT (Filed With SEC on August 13, 2001)